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Abstract
Background: A growing number of health care providers are nowadays involved in heart failure care. This could
lead to discontinuity and fragmentation of care, thus reducing trust and hence poorer medication adherence. This
study aims to explore heart failure patients’ experiences with continuity of care, and its relation to medication
adherence.
Methods: We collected data from 327 primary care patients with chronic heart failure. Experienced continuity of
care was measured using a patient questionnaire and by reviewing patients’ medical records. Continuity of care
was defined as a multidimensional concept including personal continuity (seeing the same doctor every time),
team continuity (collaboration between care providers in general practice) and cross-boundary continuity
(collaboration between general practice and hospital). Medication adherence was measured using a validated
patient questionnaire. The relation between continuity of care and medication adherence was analysed by using
chi-square tests.
Results: In total, 53% of patients stated not seeing any care provider in general practice in the last year concerning
their heart failure. Of the patients who did contact a care provider in general practice, 46% contacted two or more
care providers. Respectively 38% and 51% of patients experienced the highest levels of team and cross-boundary
continuity. In total, 14% experienced low levels of team continuity and 11% experienced low levels of
cross-boundary continuity. Higher scores on personal continuity were significantly related to better medication
adherence (p < 0.01). No clear relation was found between team- or cross-boundary continuity and medication
adherence.
Conclusions: A small majority of patients that contacted a care provider in general practice for their heart failure,
contacted only one care provider. Most heart failure patients experienced high levels of collaboration between care
providers in general practice and between GP and cardiologist. However, in a considerable number of patients,
continuity of care could still be improved. Efforts to improve personal continuity may lead to better medication
adherence.
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Background
Heart failure is a chronic disease with a high prevalence,
reaching 1-2% in western countries [1]. Its burden is
expected to rise in the coming decades due to an ageing
population and longer survival from cardiovascular dis-
ease [1,2]. Heart failure is associated with major morbidity
and high health care costs, due to high hospital admission
rates [3].
Heart failure patients, among other patients with a
chronic disease, are known to value continuity of care,
in particular seeing the same doctor (personal continu-
ity) [4]. Having a personal care provider is related to
more confidence in the care provider [5,6], more patient
satisfaction [6,7], increased feelings of being helped for-
ward [6] and higher quality of patient’s life [8,9].
However, for patients with a chronic disease, recent
developments in care can result in lack of continuity. An
increasing number of care providers is nowadays
involved in their care. Many patients contact several gen-
eral practitioners (GPs) in one practice and probably also
contact several specialists in one department. In addition,
nurse physicians and practice nurses are often involved
in the care for chronically ill patients. This could lead to
discontinuity and fragmentation of care, which in turn
may reduce trust and result in poorer medication adher-
ence [10,11]. Communication and cooperation between
all providers involved becomes increasingly important to
guarantee continuity [12-15].
Patients experiences with personal continuity are well
researched. However, little is known about patients experi-
ences with communication and cooperation between care
providers in general practice (team continuity) and be-
tween general practice and specialist care (cross-boundary
continuity).
The aim of this article is therefore to analyse the de-
gree to which heart failure patients contact their usual
care provider (personal continuity) and the degree of
communication and cooperation between several care
providers involved in the care for these heart failure
patients (team and cross-boundary continuity). We will
also analyse the relation between continuity of care and
patients’ medication adherence, for which the evidence
is still inconclusive [10,11].
Methods
Participants
In the Netherlands, every patient is enlisted with a GP who
functions as a gatekeeper for specialist care. Most heart
failure patients in the Netherlands obtain the medical care
for their heart failure by their GP on their own initiative.
Nurse practitioners have more and more taken over the
monitoring of blood pressure and other risk factors.
In the period 2005–2006, we invited 415 general prac-
tices in 15 different hospital regions to participate in this
study of which 72 GPs in 42 practices agreed to partici-
pate. These practices are representative for Dutch prac-
tices regarding urbanization rate and type of practice.
All patients with a diagnosis of chronic heart failure,
according to their GP, were eligible to be included. We
excluded patients with a terminal disease, a mental im-
pairment, Dutch language problems or when the GP
decided that patients should not be included in the study
for other reasons. The study is powered on the primary
study outcome ‘health related quality of life’. This article
focuses on continuity of care and medication adherence
as outcome measures, for which we performed no power
calculations. Ethical permission for the study was
obtained from the ethics committee Arnhem-Nijmegen.
More detailed information regarding this study has been
previously published [16].
Measurements
Continuity of care
We measured the experienced continuity of care using a
previously developed questionnaire (see Table 1 for spe-
cific items). This questionnaire is based on 30 patient
interviews that were conducted as part of a study on
continuity of care and consists of 11 items [17]. The
questionnaire was tested among six GPs/senior research-
ers and eight patients (content validity) to make sure no
significant items were missing and all items were under-
stood correctly. After the test phase, minor changes to
the questionnaire were made.
Three dimensions of continuity can be identified in the
questionnaire, corresponding to the literature [12,15,18]:
1. Personal continuity (1 item): the number of care
providers (GPs and/or nurses) that patients saw in
general practice for their heart disease in the last year.
To further analyse this dimension of continuity of
care, we also reviewed the patients’ medical records
for the total number of contacts with the general
practice in the last year. Due to limited resources, the
collection of medical record data was limited to a
random sample of maximum 15 patients per practice.
2. Team continuity in general practice (6 items): the
extent to which care providers (GPs and/or nurses)
in general practice have knowledge of the patient and
communicate and cooperate with each other.
3. Cross-boundary continuity (4 items): the extent to
which GP and cardiologist communicate and
cooperate with each other.
For the domains 2 and 3, responses were recorded on a
five-point scale (1= never, 5 = always). We tested the ques-
tionnaire in a sample of Dutch patients with COPD, heart
failure or a mental illness and subsequently performed
principal factor analysis on the 10 items of domain 2 and
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3, which confirmed the two presumed factors (construct
validity). The eigenvalues of both factors were 8.064 (team
continuity) and 1.135 (cross-boundary continuity). The
two factors together explained a total variance of 83.6%
(respectively 42.7% and 40.9%).
Medication adherence
We measured patients’ medication adherence by using
the validated measure of Morisky et al. [19]. This scale
measures self-reported intentional (two items) and unin-
tentional (two items) non-adherence to medicines. The
items can be answered on a 5-point Likert scale ranging
from 1 (no adherence) to 5 (full adherence). Medication
adherence was measured as the sum score of the four
questions, varying from 4 to a maximum of 20.
Both (anonymous) questionnaires were sent simultan-
eously by mail. In case of non-response, a reminder was
sent after three to four weeks.
Analysis
First, we explored the results on the items measuring per-
sonal, team and cross-boundary continuity. We excluded
cases in which half or more of the questions of a specific
factor were missing, i.e. 3 or more questions on team con-
tinuity or 2 or more questions on cross-boundary continu-
ity. All remaining missing values were imputed by
patient’s mean of the non-missing items on the specific
factor. The answers on the negatively keyed questions
were then recoded.
The total score of team continuity ranged from 6 to a
maximum of 30 and the total score of cross-boundary
continuity ranged from 4 to a maximum of 20. Due to the
wide range in total scores, we sub-classified the total score
of team and cross-boundary continuity into 5 subcategor-
ies. These categories consisted of the maximum score and
subsequently 4 subcategories with an equal range. For
team continuity: (1) 30 (max), (2) 24–29, (3) 18–23, (4)
12–17 and (5) 6–11. For cross-boundary continuity: (1) 20
(max), (2) 16–19, (3) 12–15, (4) 8–11 and (5) 4–7.
We sub-classified the total score of team and cross-
boundary continuity into 5 subcategories: the maximum
score and subsequently 4 equal subcategories.
All analyses were performed using SPSS 16. We ana-
lysed the relation between continuity of care and
patients’ medication adherence by using chi-square tests.
A p-value <0.05 was considered statistically significant.
Table 1 Results of items measuring continuity of care
Personal continuity in general practice 0 1 2 3 4 or more
1. How many different care providers have you seen in general 161 (53.1%) 76 (25.1%) 42 (13.9%) 19 (6.3%) 5 (1.7%)
practice in the last year for your heart disease? (n = 303)
2. Total number of contacts with general practice in last year 10 (4.1%) 9 (3.7%) 14 (5.7%) 16 (6.5%) 196 (80.0%)
(according to medical record) (n = 245)
Team continuity in general practice Never Seldom Sometimes Often Always
1. The treatment of my heart disease in general practice 25 (10.0%) 9 (3.6%) 19 (7.6%) 43 (17.3%) 153 (61.4%)
goes smoothly (n = 249)
2. The care of the different care providers in general practice 21 (8.2%) 11 (4.3%) 18 (7.1%) 63 (24.7%) 142 (55.7%)
for my heart disease is connected (n = 255)
3. The care providers in general practice often give me 129 (49.8%) 79 (30.5%) 29 (11.2%) 8 (3.1%) 14 (5.4%)
contradictory advice about my heart disease (n = 259)
4. The care providers in general practice involved in the care 21 (8.2%) 7 (2.7%) 24 (9.3%) 64 (24.9%) 141 (54.9%)
for my heart disease communicate well with each other (n = 257)
5. The care providers in general practice involved in the care 12 (4.7%) 11 (4.3%) 31 (12.2%) 54 (21.2%) 147 (57.6%)
for my heart disease have knowledge of my medical record (n = 255)
6. The care providers in general practice involved in the care 20 (7.9%) 12 (4.7%) 27 (10.7%) 50 (19.8%) 144 (56.9%)
for my heart disease have knowledge of previous visits (n = 253)
Cross-boundary continuity Never Seldom Sometimes Often Always
1. The care of the GP and the cardiologist is connected (n = 191) 9 (4.7%) 12 (6.3%) 11 (5.8%) 38 (19.9%) 121 (63.4%)
2. The GP and the cardiologist often give me contradictory 110 (56.4%) 48 (24.6%) 22 (11.3%) 9 (4.6%) 6 (3.1%)
advice about my heart disease (n = 195)
3. The GP and the cardiologist transfer information about 9 (4.6%) 11 (5.6%) 14 (7.2%) 37 (19.0%) 124 (63.6%)
my heart disease well between each other (n = 195)
4. The GP and the cardiologist communicate well (n = 190) 12 (6.3%) 12 (6.3%) 17 (8.9%) 40 (21.1%) 109 (57.4%)
GP: General practitioner; Items are measured using a patient questionnaire unless otherwise indicated.
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Analyses were performed both including and exclud-
ing the patients that did not have contact with any care
provider in general practice in the last year for their
heart failure. As the results in both analyses did not dif-
fer, we present the analyses including these patients in
this article.
Results
We sent the questionnaire measuring continuity of care
to 461 patients. In total, 370 patients (80%) responded.
We excluded 43 patients due to missing values (3 or
more questions on team continuity or 2 or more ques-
tions on cross-boundary continuity). Consequently, we
analysed data from 327 patients. Most patients were
Dutch (93%), above 70 years of age (73%) and could be
classified as NYHA class I (49%). Patients’ sex was
equally distributed (Table 2).
Levels of experienced continuity
Table 1 shows the results of the items measuring con-
tinuity of care. A total of 53% of patients stated not see-
ing any care provider (GP or nurse) in general practice
in the last year for their heart failure. In total, 54% of
these patients that did not contact their general practice,
did contact a cardiologist in the last year. Based on the
medical record review, we found that only 10 patients
(4.1%) did not have any contact with a care provider in
general practice at all in the last year.
In total, 25% saw one care provider in general practice
for their heart failure, 14% saw two care providers and
8% of patients saw 3 or more care providers in general
practice.
The questions concerning team continuity and cross-
boundary continuity mostly scored positive: each item
scored maximum by at least half of the patients.
Table 3 shows the total score of team and cross-
boundary continuity. Almost 38% of patients experi-
enced maximum team continuity (score 30), while 51%
of patients experienced maximum cross-boundary con-
tinuity (score 20). Respectively 14% and 11% of patients
experienced very low levels of team and cross-
boundary continuity (total score less than 18 or 12,
respectively).
Continuity and medication adherence
In total, 74% of patients were fully adherent (score 20),
15% scored 19 points on the medication adherence
measure, 7% scored 18 points and 5% scored 17 points
or less.
Table 4 shows the relation between experienced con-
tinuity of care and patients’ medication adherence.
Patients who saw three or more care providers in gen-
eral practice were less likely to be fully adherent than
patients who saw less care providers (p < 0.01). We
found a non-linear relation between experienced team
continuity and medication adherence: both high and low
levels of team continuity were associated with maximum
medication adherence, while the mid-levels of team con-
tinuity were associated with the lowest medication ad-
herence (p = 0.04). No relation was found between cross-
boundary continuity and medication adherence.
Table 2 Characteristics of the study population (n= 327)
Age, mean (SD) 74.9 (10.1)
<65 54 (16.5%)
65-70 33 (10.1%)
71-75 59 (18.0%)
76-80 78 (23.9%)
81-85 62 (19.0%)
>85 41 (12.5%)
Sex
Male 164 (50.2%)
Female 163 (49.8%)
Nationality
Dutch 305 (93.3%)
Other 12 (3.7%)
Missing 10 (3.1%)
NYHA class
Class I 159 (48.6%)
Class II 72 (22.0%)
Class III 87 (26.6%)
Class IV 7 (2.1%)
Missing 2 (0.6%)
SD: standard deviation, NYHA: New York Heart Association.
Table 3 Total score of team and cross-boundary
continuity
Team continuity in general practice (n = 261)
30 99 (37.9%)
24-29 94 (36.0%)
18-23 32 (12.3%)
12-17 18 (6.9%)
6-11 18 (6.9%)
Cross-boundary continuity (n = 195)
20 99 (50.8%)
16-19 50 (25.6%)
12-15 24 (12.3%)
8-11 12 (6.2%)
4-7 10 (5.1%)
The score of team continuity varied between 6 (minimum) and 30 (maximum).
The score of cross-boundary continuity varied between 4 (minimum) and 20
(maximum).
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Discussion
Based on a self-report, we found that more than half of
the patients did not contact any care provider in general
practice for their heart failure in the last year, though
half of them did have contact with a cardiologist. About
half of the patients who did contact general practice, had
contact with two or more care providers. Most patients
experienced acceptable levels of communication and co-
operation between care providers in general practice and
between GP and cardiologist, while 10-15% experienced
very low levels.
Medication adherence was significantly less in patients
who saw three or more care providers. Patients who did
not contact any care provider at all in the last year had
high levels of medication adherence. Team continuity
was related to medication adherence, but in a non-linear
way. No relation was found between cross-boundary
continuity and medication adherence (p = 0.19).
Implications for practice and research
We found that better personal continuity is also related
to better medication adherence. Better medication ad-
herence may lead to lower hospitalization rates, lower
morbidity and mortality and lower health care costs [20-
23]. Most Dutch heart failure patients experience high
levels of personal, team and cross-boundary continuity
of care. However, in a considerable amount of patients,
personal continuity can be improved in order to achieve
more confidence in the care provider, more patient satis-
faction and higher quality of patient’s life.
A possible explanation for the relation between per-
sonal continuity and medication adherence could be that
patients have less trust in care providers when contact-
ing more care providers [24]. Nowadays, an increasing
number of care providers work part-time, thus making it
more likely for a patient to have contact with more than
one care provider. Nevertheless, we think personal con-
tinuity can still be improved as most contacts are non-
urgent, making it possible to make an appointment with
their own care provider.
When more care providers are involved in the care of
a patient, we found that team and cross-boundary con-
tinuity can be improved in at least 10-15% of patients.
Team and cross-boundary continuity can for example be
improved by better communication between care provi-
ders (e.g. better registration in the electronic medical
record and faster communication by mail between gen-
eral practitioner and specialist).
The importance of the non-linear relationship between
team continuity and medication adherence is unknown.
It should be interpreted with caution. More research is
needed before firm conclusions can be drawn about this
relationship.
Comparison with previous studies
Previous studies found comparable levels of experienced
continuity of care [6,25-27].
Table 4 Relation between continuity of care and medication adherence
Medication adherence
17 or less 18 19 20 (maximum)
Personal continuity in general practice (p < 0.01)
0 care providers 4 (2.6%) 5 (3.2%) 28 (17.9%) 119 (76.3%)
1 care provider 9 (12.0%) 6 (8.0%) 5 (6.7%) 55 (73.3%)
2 care providers 1 (2.4%) 5 (12.2%) 4 (9.8%) 31 (75.6%)
3 or more care providers 0 (0.0%) 4 (16.7%) 4 (16.7%) 16 (66.7%)
Team continuity in general practice (p = 0.04)
30 3 (3.0%) 4 (4.0%) 11 (11.1%) 81 (81.8%)
24-29 5 (5.3%) 8 (8.5%) 15 (16.0%) 66 (70.2%)
18-23 3 (9.7%) 6 (19.4%) 6 (19.4%) 16 (51.6%)
12-17 3 (17.6%) 0 (0.0%) 1 (5.9%) 13 (76.5%)
6-11 0 (0.0%) 2 (11.8%) 3 (17.6%) 12 (70.6%)
Cross-boundary continuity (p = 0.19)
20 2 (2.1%) 3 (3.1%) 14 (14.6%) 77 (80.2%)
16-19 3 (6.1%) 4 (8.2%) 10 (20.4%) 32 (65.3%)
12-15 1 (4.3%) 3 (13.0%) 2 (8.7%) 17 (73.9%)
8-11 0 (0.0%) 3 (25.0%) 1 (8.3%) 8 (66.7%)
4-7 1 (11.1%) 0 (0.0%) 1 (11.1%) 7 (77.8%)
Medication adherence varied between 4 (minimum) and 20 (maximum). Because of the small number of patients scoring 17 or less, we grouped these patients
together.
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We found only two studies investigating the relation
between personal continuity and medication adherence.
One of them found a positive relation between seeing
the care provider who prescribed the medication and
medication adherence [10], while the other study found
no relation between the proportion of consultations with
the usual physician and medication adherence [11]. We
found no studies investigating the relation between team
or cross-boundary continuity and medication adherence.
Limitations
One of the limitations of this study is that 53% of patients
answered that they did not see any care provider in gen-
eral practice in the last year for their heart failure. How-
ever, most of these patients did fill in the other continuity
questions, which can make the reliability of the answers
doubtful. We made the assumption that most of the
patients stating not have seen any care provider in general
practice in the last year for their heart failure, saw their
GP for other disorders in that year during which the GP
also monitored their heart failure (e.g. blood pressure).
This assumption is strengthened by the fact that, based on
the medical record search, only 10 patients (4.1%) did not
have any contact at all with a care provider in general
practice in the last year. The results of the analyses of the
data including and excluding these patients did not differ.
Another limitation is the cross-sectional design of this
study. As a consequence, we can only hypothesize about
the causality of the relation between continuity and
medication adherence and our results should be inter-
preted with caution.
A last limitation is that the study is powered on the
outcome measure ‘health related quality of life’. Possibly,
too few patients were included to find a relation between
team- or cross-boundary continuity and medication
adherence.
Conclusions
A small majority of patients that contacted a care provider
in general practice for their heart failure, contacted only
one care provider (personal continuity). Most heart failure
patients experienced high levels of collaboration between
care providers in general practice (team continuity) and
between GP and cardiologist (cross-boundary continuity).
However, in a considerable amount of patients continuity
can still be improved. Efforts to improve personal con-
tinuity may lead to better medication adherence.
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